Emerson (EMR) stock tumbled 5.31% in pre-market trading on Wednesday following the release of its third-quarter 2025 earnings report. Despite beating earnings estimates, the company's revenue fell short of expectations, potentially triggering investor concerns about its growth trajectory.

The industrial technology giant reported adjusted earnings per share of $1.52, slightly above the $1.51 analyst estimate. However, sales for the quarter came in at $4,553 million, missing the anticipated $4,597 million. The company's operating cash flow stood at $1,062 million for the quarter.

Looking ahead, Emerson provided guidance that seems to have failed to impress investors. For the full fiscal year 2025, the company expects adjusted earnings per share of $6.00 and revenue growth of 3.5%. The fourth-quarter outlook projects net sales growth of 5.5% to 6.5% and underlying sales growth of 5% to 6%. While these figures align closely with analyst expectations of $5.99 EPS and $18.11 billion in revenue for the fiscal year, they may not have been robust enough to maintain investor confidence.